Romiplostim expands the Treatment Options for ITP

被引：0
|
作者：
不详
机构：
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2012年 / 39卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [41] COST-CONSEQUENCE ANALYSIS COMPARING ROMIPLOSTIM TO RITUXIMAB IN THE TREATMENT OF ADULT PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN GERMANY
    von Depka, M.
    Salama, A.
    Perrin, A.
    Oelze, I.
    Chulikavit, M.
    Kunz, E.
    Kutikova, L.
    Thalheimer, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 427 - 427
  • [42] Treatment options for persisting thrombocytopenia after allogeneic stem cell transplantation using romiplostim
    Moskovits, J.
    Ponstingl, E.
    Jarisch, A.
    Soerensen, J.
    Bakhtiar, S.
    Klingebiel, T.
    Bader, P.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S408 - S408
  • [43] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    [J]. HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [44] Impact Assessment of Immunogenicity of Romiplostim In Subjects with Immune Thrombocytopenic Purpura (ITP).
    Pamma, Rupinderjit
    Deshpande, Meghana
    Hokom, Martha
    Gupta, Shalini
    Zhuang, Yao
    Chirmule, Naren
    Swanson, Steve
    Jawa, Vibha
    [J]. BLOOD, 2010, 116 (21) : 1043 - 1043
  • [45] Extension for Romiplostim (Nplate®): ITP-Therapy regardless of Splenectomy Status
    Kipper, Fulvia
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2016, 43 (03) : 235 - 235
  • [46] Mack expands truck options
    不详
    [J]. DIESEL PROGRESS NORTH AMERICAN EDITION, 2004, 70 (08): : 28 - 28
  • [47] Molecular classification of cancers of unknown primary expands and refines treatment options
    George, D. J.
    Moore, E.
    Blobe, G. C.
    DeVito, N.
    Hanks, B. A.
    Harrison, M. R.
    Hoimes, C. J.
    Jia, J.
    Morse, M.
    Jayaprakasan, P.
    MacKelfresh, A.
    Mulder, H.
    Beauchamp, K.
    Michuda, J.
    Stumpe, M. C.
    Perakslis, E.
    Taxter, T.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S968 - S969
  • [48] GLP-1-Receptor Agonist expands Treatment Options for Obesity
    Aberle, Jens
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (09) : 1 - 1
  • [49] COST-CONSEQUENCE ANALYSIS COMPARING ROMIPLOSTIM TO RITUXIMAB IN THE TREATMENT OF ADULT PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN FRANCE
    Chiche, L.
    Lefrere, F.
    Chulikavit, M.
    Perrin, A.
    Stern, L.
    Bischof, M.
    Cohen, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A415 - A415
  • [50] Case Studies Of Re mission In Adults With Immune Thrombocytopenia (ITP) Following Cessation Of Treatment With The TPO Receptor Agonist Romiplostim
    Bussel, James B.
    Wang, Xuena
    Eisen, Melissa
    [J]. BLOOD, 2013, 122 (21)
12345